Showing results (401-410 of 4,241) with videos related to
Sort By:
Pageof 425
Journal for Immunotherapy of Cancer|April 24, 2025
CLN-619, a MICA/B monoclonal antibody that promotes innate immune cell-mediated antitumor activityKerry A Whalen, Catherine C Henry, Naveen K Mehta, et al.Journal for Immunotherapy of Cancer|May 2, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoireLeonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.Journal for Immunotherapy of Cancer|May 2, 2025
Targeting nerve growth factor: an Achilles' heel for tumors?Elizabeth Repasky, Hemn MohammadpourJournal for Immunotherapy of Cancer|May 2, 2025
RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicityHui Guo, Jie Hu, Zining Wang, et al.Journal for Immunotherapy of Cancer|April 20, 2025
Reversible downregulation of HLA class I in adenoid cystic carcinomaAnnie Li, Bianca L Gonda, Elizabeth M Codd, et al.Journal for Immunotherapy of Cancer|April 20, 2025
Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategiesCristina Bayó, Giancarlo Castellano, Fátima Marín, et al.Journal for Immunotherapy of Cancer|April 24, 2025
Gut microbiota derived indole-3-acetic acid ameliorates precancerous inflammatory intestinal milieu to inhibit tumorigenesis through IL-35Juanjuan Wang, Yang Hao, Yazheng Yang, et al.Journal for Immunotherapy of Cancer|March 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in miceAlexandra Fauvre, Chiara Ursino, Veronique Garambois, et al.Journal for Immunotherapy of Cancer|March 26, 2025
Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironmentWen-Ling Chen, Yong-Lin Chang, Su-Fang Lin, et al.Journal for Immunotherapy of Cancer|March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanomaLi Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.Pageof 425